Virtu Financial’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-2,325
Closed -$571K – 2486
2022
Q3
$571K Buy
+2,325
New +$628K 0.05% 337
2021
Q4
– Sell
-1,184
Closed -$385K – 2375
2021
Q3
$385K Buy
+1,184
New +$401K 0.03% 587
2020
Q4
– Sell
-3,189
Closed -$884K – 1915
2020
Q3
$884K Buy
+3,189
New +$919K 0.15% 145
2019
Q4
$273K Sell
1,602
-1,570
-49% -$291K 0.03% 740
2019
Q3
$564K Buy
+3,172
New +$686K 0.04% 471
2019
Q2
– Sell
-9,055
Closed -$2.59M – 1997
2019
Q1
$2.59M Buy
+9,055
New +$3.01M 0.15% 89
2018
Q4
– Sell
-2,265
Closed -$1.02M – 2107
2018
Q3
$1.02M Sell
2,265
-7,713
-77% -$3.04M 0.06% 322
2018
Q2
$4.08M Buy
+9,978
New +$3.61M 0.25% 47
2018
Q1
– Sell
-5,782
Closed -$1.08M – 2815
2017
Q4
$1.08M Buy
5,782
+2,587
+81% +$483K 0.06% 406
2017
Q3
$539K Buy
+3,195
New +$483K 0.03% 865

Other funds holding ABMD

Virtu Financial's ABMD Position: Q4 2022 in Review

Virtu Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,325 shares — an estimated $571K sold.

Virtu Financial first reported a position in ABMD in Q3 2017 and held it in 10 quarters. The position peaked at $4.08M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Virtu Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 2,325 Abiomed Inc shares in Q4 2022, an estimated $571K.
  • Virtu Financial first reported a position in Abiomed Inc in Q3 2017 and held it in 10 quarters.
  • Virtu Financial's Abiomed Inc position peaked at $4.08M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.